Navigation Links
Biotrial, a Leading Provider of Drug Development Services, Has Completed its Acquisition of Warnex Bioanalytical Services Division
Date:2/22/2013

(PRWEB) February 22, 2013

The acquisition of the Warnex Bioanalytical Services division allows Biotrial to broaden its drug development services to its international clients, giving them access to the full spectrum of Bioanalytical services to support preclinical and clinical development, including generics product development. To complement the service offering, Warnex clients now have access to the large range of existing Biotrial drug development services.

The new Biotrial addition includes: a team of highly experienced experts including a staff of over 70, more than 250 validated assays, 25 000 sq. ft. cutting edge laboratories and work stations, over 20 Mass Spectrometers and a validated Watson® LIMS.

BBS services have a SCC certification; have been audited by the FDA and AGES regulatory agencies. Services offered include: method development & validation, preclinical, bioavailability and bioequivalence studies, as well as therapeutic drug monitoring.

Jean-Marc Gandon, Pharm.D., President & CEO of Biotrial, says: “We have been looking for many years to find the right partner to complement our offer with sample analysis so that our customers could benefit from a full package in their process of developing new drugs or generics. Because of its ability to meet the growing needs of the pharmaceutical industry and to use the latest technology Warnex became an obvious choice. Biotrial is committed to continue providing the excellent service and quality of science for which the Montreal site is known for, by continuing its investment in the latest state-of-the-art equipment.”

Michael Mancini, Ph.D., BBS Inc. President, affirms: “It has been a very smooth transition and we are particularly excited to officially be a part of the Biotrial team. There is no change in management or staff and for us it is ‘business as usual.’ Being a part of such an international and well recognized CRO ensures that we will continue to expand our service offering as we have been doing for so many years.”

With the Bioanalytical acquisition Biotrial continues its expansion into the North American market which, will be complemented by the opening of an additional Clinical Unit in New Jersey later this year.

About Biotrial
Founded in 1989, Biotrial is a leading CRO specialized in Early Development with a large range of services from Non-Clinical Pharmacology, Phase I studies, Phase II-IV Trial Management, Bioanalytical analysis, Oncology, Data Management, Biostatistics, ECG & Imaging Core Lab (QT/QTc Trials, Psychometric Testing, Imaging, EEG/PSG Assessment), Regulatory Affairs to Medical Writing.

Based in France, Belgium, the United Kingdom, Canada and the United States, Biotrial performs hundreds of studies a year and offers tailor-made solutions to Biotech and Pharmaceutical companies.

For further information please contact Anne Peron at [+33] (0)2 99 599 191 or visit [http://www.biotrial.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10454568.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Plunketts Biotech & Genetics Industry Almanac 2013: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
2. PROLOR Biotech To Present New Preclinical Data On Its Long-Acting Clotting Factor VIIa At Leading European Scientific Conference
3. ViaCytes Role as a Leading Cell Therapy Company Bolstered with the Issuance of 20 Patents in 2012
4. Agency Take-up Soars of Agnitios Leading Pull Marketing Platform for the Healthcare Industry
5. LATISTA Announces Next-Generation iPad App 2.0 for Construction with Industry Leading Innovations
6. The Leading Edge Of Medical Innovation: New Prenatal Genetic Tests Use Moms Blood To Learn About Her Baby
7. Crisalix Awarded as a Leading Life Science Company that is Revolutionizing the Medical Industry
8. Speech and Language Therapy Jobs and Biomedical Science Jobs - Medicspro Leading the way for Medical Recruitment Agencies in the UK
9. Japan Bioinformatics Announces Study on Leading Mapping Tools for DNA Mutation Discovery
10. A leading Massachusetts-based IT and Life Sciences staffing and consulting firm has opened two new offices in the Ohio Valley
11. Maker of leading in-home HIV test encourages testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... PUNE, India , March 22, 2016 ... new market research report "Electronic Sensors Market for ... Fingerprint, Proximity, & Others), Application (Communication & ... and Geography - Global Forecast to 2022", ... consumer industry is expected to reach USD ...
Breaking Biology News(10 mins):